title: [Patients with advanced ovarian cancer after negative second-look laparoscopy--follow up study].
abstract: OBJECTIVE
  Follow-up in 65 patients with stage III-IV ovarian cancer after negative second-look laparotomy. Prognostic factors and causes of failure were also discussed.
  
  
  METHODS
  65 patients with ovarian cancer stage III-IV were treated with surgery and at least six courses of chemotherapy (cisplatin, adriamycin, cyclophosphamide) and second-look laparotomy. Results of the treatment are presented in a form of 5-year NED (no evidence of disease) survival. Dependence between analyzed factors and survival was assessment based on proportional hazard Cox model.
  
  
  RESULTS
  In 30 patients (46.1%) recurrence during 5 year follow-up was observed. In 28 patients out of them (93.3%) it was loco-regional failure and in 2 patients distant metastases were the sole reason of unsuccessful results of the treatment. Adverse prognostic factors found in statistical analysis were: advanced primary stage, residual infiltrations after first laparotomy exceeding 2 cm and low grade of differentiation.
  
  
  CONCLUSIONS
  1. In about 50% of patient with advanced ovarian cancer loco-regional recurrence was observed, 2. Adverse prognostic factors were: advanced primary stage, residual masses after first laparotomy above 2 cm and low grade of differentiation.
authors.affiliation: Kliniki Ginekologii Onkologicznej Krakowskiego Oddziału Centrum Onkologii.
authors.forename: Jacek
authors.initials: J
authors.lastname: Pudełek
authors.forename: Zbigniew
authors.initials: Z
authors.lastname: Kojs
authors.forename: Krzysztof
authors.initials: K
authors.lastname: Urbański
authors.forename: Jerzy
authors.initials: J
authors.lastname: Mituś
authors.forename: Marian
authors.initials: M
authors.lastname: Reinfuss
authors.forename: Małgorzata
authors.initials: M
authors.lastname: Klimek
mesh_terms: D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007813:Laparotomy; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy / Q000473:pathology / Q000601:surgery; D009367:Neoplasm Staging; D010051:Ovarian Neoplasms / Q000188:drug therapy / Q000473:pathology / Q000601:surgery; D011379:Prognosis; D016016:Proportional Hazards Models; D012044:Regression Analysis; D012307:Risk Factors; D024162:Second-Look Surgery; D016019:Survival Analysis; D013997:Time Factors